Capricor Therapeutics
CAPR
#8024
Rank
โ‚น26.35 B
Marketcap
โ‚น576.43
Share price
-4.36%
Change (1 day)
-53.94%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: โ‚น26.35 Billion

As of February 2026 Capricor Therapeutics has a market cap of โ‚น26.35 Billion. This makes Capricor Therapeutics the world's 8024th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น26.35 B0.96%
2025โ‚น26.10 B-52.47%
2024โ‚น54.92 B338.14%
2023โ‚น12.53 B55.48%
2022โ‚น8.06 B53.09%
2021โ‚น5.26 B2.68%
2020โ‚น5.12 B974.98%
2019โ‚น0.47 B-46.97%
2018โ‚น0.89 B-65.31%
2017โ‚น2.59 B-32.94%
2016โ‚น3.86 B16.5%
2015โ‚น3.32 B19.33%
2014โ‚น2.78 B18.56%
2013โ‚น2.34 B1943.76%
2012โ‚น0.11 B-89.97%
2011โ‚น1.14 B18.99%
2010โ‚น0.96 B-36.73%
2009โ‚น1.52 B54.13%
2008โ‚น0.98 B-81.03%
2007โ‚น5.20 B3789.04%
2006โ‚น0.13 B-39.43%
2005โ‚น0.22 B3.91%
2004โ‚น0.21 B21.23%
2003โ‚น0.17 B-65.41%
2002โ‚น0.50 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of Capricor Therapeutics was reported to be:

โ‚น107.94 Billion
by Nasdaq info icon info icon
โ‚น26.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น51.924 T 196,931.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.246 T 4,629.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚น667.54 B 2,433.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น135.98 B 416.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น2.47 B-90.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.48 B-98.16%๐Ÿ‡บ๐Ÿ‡ธ USA